GSK 870086

Drug Profile

GSK 870086

Alternative Names: 870086; GSK870086; GW-870086X

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antiasthmatics
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Asthma; Atopic dermatitis

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 04 Aug 2011 GlaxoSmithKline completes a phase II trial in Asthma in Bulgaria, Germany, and South Africa (NCT01245426)
  • 19 May 2011 GlaxoSmithKline completes enrolment in its phase II trial for Asthma in Bulgaria, Germany & South Africa (NCT01245426)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top